It is vitally important that we understand whether mRNA vaccines are capable of generating high‐affinity, longlived immune memory cells to SARS‐CoV‐2. To this end, a recent study by Ellebedy, Kim and colleagues provide much‐needed insight into the production and quality of humoral immune cells generated by the BNT162b2 vaccine.
All Keywords